Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIMTA LABS vs LINK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VIMTA LABS LINK PHARMA VIMTA LABS/
LINK PHARMA
 
P/E (TTM) x 32.8 38.0 86.4% View Chart
P/BV x 5.4 1.3 416.1% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 VIMTA LABS   LINK PHARMA
EQUITY SHARE DATA
    VIMTA LABS
Mar-24
LINK PHARMA
Mar-24
VIMTA LABS/
LINK PHARMA
5-Yr Chart
Click to enlarge
High Rs62169 903.6%   
Low Rs31734 929.3%   
Sales per share (Unadj.) Rs143.667.3 213.2%  
Earnings per share (Unadj.) Rs18.5-3.1 -602.6%  
Cash flow per share (Unadj.) Rs33.9-0.7 -4,577.9%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs141.230.9 457.2%  
Shares outstanding (eoy) m22.174.44 499.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.30.8 427.8%   
Avg P/E ratio x25.4-16.8 -151.4%  
P/CF ratio (eoy) x13.8-69.5 -19.9%  
Price / Book Value ratio x3.31.7 199.5%  
Dividend payout %10.80-   
Avg Mkt Cap Rs m10,402228 4,554.0%   
No. of employees `000NANA-   
Total wages/salary Rs m95355 1,727.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,183299 1,064.5%  
Other income Rs m406 626.1%   
Total revenues Rs m3,223305 1,055.3%   
Gross profit Rs m868-7 -13,352.5%  
Depreciation Rs m34210 3,307.1%   
Interest Rs m219 243.3%   
Profit before tax Rs m545-19 -2,843.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m135-6 -2,436.2%   
Profit after tax Rs m410-14 -3,008.7%  
Gross profit margin %27.3-2.2 -1,254.7%  
Effective tax rate %24.728.9 85.7%   
Net profit margin %12.9-4.6 -282.7%  
BALANCE SHEET DATA
Current assets Rs m1,576115 1,367.3%   
Current liabilities Rs m541110 491.3%   
Net working cap to sales %32.51.7 1,866.7%  
Current ratio x2.91.0 278.3%  
Inventory Days Days655 10.4%  
Debtors Days Days100629 15.9%  
Net fixed assets Rs m2,347144 1,626.8%   
Share capital Rs m4444 99.8%   
"Free" reserves Rs m3,08693 3,329.3%   
Net worth Rs m3,130137 2,283.1%   
Long term debt Rs m9111 857.7%   
Total assets Rs m3,923260 1,511.6%  
Interest coverage x26.7-1.2 -2,228.0%   
Debt to equity ratio x00.1 37.6%  
Sales to assets ratio x0.81.2 70.4%   
Return on assets %11.0-1.9 -581.3%  
Return on equity %13.1-9.9 -131.8%  
Return on capital %17.6-7.1 -248.7%  
Exports to sales %26.60-   
Imports to sales %00-   
Exports (fob) Rs m845NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8450-   
Fx outflow Rs m1540-   
Net fx Rs m6910-   
CASH FLOW
From Operations Rs m6090 -217,471.4%  
From Investments Rs m-7604 -18,777.3%  
From Financial Activity Rs m-19-4 467.6%  
Net Cashflow Rs m-1710 56,863.3%  

Share Holding

Indian Promoters % 36.9 51.5 71.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.3 0.0 16,550.0%  
FIIs % 3.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 63.1 48.5 130.1%  
Shareholders   20,114 6,151 327.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VIMTA LABS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VIMTA LABS vs LINK PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VIMTA LABS vs LINK PHARMA Share Price Performance

Period VIMTA LABS LINK PHARMA
1-Day 2.97% -0.86%
1-Month 36.09% -4.09%
1-Year 78.26% -11.43%
3-Year CAGR 29.63% 5.88%
5-Year CAGR 49.35% 24.27%

* Compound Annual Growth Rate

Here are more details on the VIMTA LABS share price and the LINK PHARMA share price.

Moving on to shareholding structures...

The promoters of VIMTA LABS hold a 36.9% stake in the company. In case of LINK PHARMA the stake stands at 51.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VIMTA LABS and the shareholding pattern of LINK PHARMA.

Finally, a word on dividends...

In the most recent financial year, VIMTA LABS paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 10.8%.

LINK PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of VIMTA LABS, and the dividend history of LINK PHARMA.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.